To compare the clinical profile of long-term survivors and nonsurvivors with type 1 diabetes (T1D) in India.
Research Design and Methods:
This is a retrospective study of 76 individuals with T1D who had survived for at least 40 years (“survivors”) and 51 individuals with T1D who had died with shorter duration of diabetes (“non-survivors”), from diabetes clinics in different cities of India. Prevalence of complications in both groups and causes of death of the nonsurvivors were analyzed. Retinopathy was diagnosed by retinal photography; chronic kidney disease (CKD) by urinary albumin excretion (micro-or macroalbuminuria) and estimated glomerular filtration rate; peripheral vascular disease (PVD) by doppler measurement of ankle-brachial pressure index; coronary artery disease (CAD) based on history of myocardial infarction or coronary revascularization, and neuropathy by biothesiometry.
Results:
Mean glycated hemoglobin (8.4% ± 1.5% vs. 10.7% ± 2.2%, P < 0.001), serum low-density lipoprotein cholesterol (91 ± 29 mg/dL vs. 107 ± 22 mg/dL, P = 0.004), and systolic blood pressure (135 ± 16 mmHg vs. 153 ± 37 mmHg, P = 0.003) were lower, and high-density lipoprotein cholesterol (51 ± 11 mg/dL vs. 43 ± 15 mg/dL, P = 0.002) higher, among survivors compared to nonsurvivors. Diabetic retinopathy, CKD, neuropathy, PVD, and CAD were more frequent among nonsurvivors. CAD [25.5%] and renal failure [23.5%] were the most frequent causes of death.
Conclusions:
In this first report of long-term survivors with T1D from India, we report that survivors had better glycemic and blood pressure control, more favorable lipid profiles and lower prevalence of complications compared to nonsurvivors. However, there could be other protective factors as well, which merit further studies.
Get full access to this article
View all access options for this article.
References
1.
ElsamahyMH, ElhenawyYI, AltayebN: Long-term prognosis of type 1 diabetes in relation to the clinical characteristics at the onset of diabetes. Egypt Pediatr Assoc Gazette, 2017; 65:90–94.
2.
BrownLJ, ScottRS, MoirCL: All-cause mortality in the Canterbury (New Zealand) insulin-treated Diabetic Registry population. Diabetes Care, 2001; 24:56–63.
3.
MillerRG, SecrestAM, SharmaRK, et al.: Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort. Diabetes, 2012; 61:2987–2992.
4.
LuharS, KondalD, JonesR, et al.: Lifetime risk of diabetes in metropolitan cities in India. Diabetologia, 2021; 64:521–529.
5.
Borch-JohnsenK, AndersenPK, DeckertT: The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia, 1985; 28:590–596.
6.
ParvingHH, HommelE: Prognosis in diabetic nephropathy. Br Med J, 1989; 299:230–233.
7.
AndersonAR, ChristiansenJS, AndersonJK, et al.: Diabetic nephropathy in Type I (insulin-dependent) diabetes. an Epidemiol Study Diabetologia, 1983; 25:496–501.
8.
Borch-JohnsenK, NissenH, SallingN, et al.: The natural history of insulin-dependent diabetes in Denmark: 2. Long-term survival—who and why. Diabetologia, 1987; 4:211–216.
9.
TachkovK., MitovK., KolevaY, et al.: Life expectancy and survival analysis of patients with diabetes compared to the non-diabetic population in Bulgaria. PLoS One, 2020; 15:e0232815.
10.
BainSC, GillGV, DyerPH, et al.: Characteristics of T1D of over 50 years duration (the Golden Years Cohort). Diabet Med, 2003; 20:808–811.
11.
SunJK, KeenanHA, CavalleranoJD, et al.: Protection from retinopathy and other complications in patients with T1Dof extreme duration: the Joslin 50-year medalist study. Diabetes Care, 2011; 34:968–974.
12.
The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993; 329:977–986.
13.
Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group: Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care, 1999; 22:99–111.
SRS based abridged life tables. https://censusindia.gov.in/Vital_Statistics/SRS_Life_Table/SRS%20based%20Abridged%20Life%20Tables%202013-17.pdf (accessed May30, 2021).
16.
MohanV, Shanthi RaniCS, AmuthaA, et al.: Clinical profile of long-term survivors and non-survivors with type 2 diabetes. Diabetes Care, 2013; 36:2190–2197.
17.
PradeepaR, PrabuAV, JebaraniS, et al.: Use of a large diabetes electronic medical record system in India: clinical and research applications. J Diabetes Sci Technol, 2011; 5:543–552.
18.
AmuthaA, AnjanaRM, VenkatesanU, et al.: Incidence of complications in young-onset diabetes: comparing type 2 with type 1 (the young diab study). Diabetes Res Clin Pract, 2017; 123:1–8.
19.
FriedewaldWT, LevyRI, FredricksonDS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem, 1972; 18:499–502.
20.
RamachandranA, MohanV, SnehalathaC, et al.: Clinical features of diabetes in the young as seen at a diabetes centre in south India. Diabetes Res Clin Pract, 1988; 4:117–125.
21.
AmuthaA, DattaM, UnnikrishnanR, et al.: Clinical profile and complications of childhood- and adolescent-onset type 2 diabetes seen at a diabetes centre in south India. Diabetes Technol Ther, 2012; 14:497–504.
22.
AmuthaA, DattaM, UnnikrishnanIR, et al.: Clinical profile of diabetes in the young seen between 1992 and 2009 at a specialist diabetes centre in south India. Prim Care Diabetes, 2011; 5:223–229.
23.
ChobanianAV, BakrisGL, BlackHR, et al.: The seventh report of the joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA, 2003; 289:2560–2572.
24.
Expert Panel onDetection, Evaluation, and Treatment of High Blood Cholesterol inAdults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 2001; 285:2486–2497.
25.
Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology, 1991; 98:786–806.
26.
UnnikrishnanRI, RemaM, PradeepaR, et al.: Prevalence and risk factors of diabetic nephropathy in an urban South Indian population: the Chennai Urban Rural Epidemiology Study (CURES 45). Diabetes Care, 2007; 30:2019–2024.
27.
Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med, 2013; 158:825–830.
28.
PradeepaR, RemaM, VigneshJ, et al.: Prevalence and risk factors for diabetic neuropathy in an urban south Indian population: the Chennai Urban Rural Epidemiology Study (CURES-55). Diabet Med, 2008; 25:407–412.
29.
PremalathaG, ShanthiraniS, DeepaR, et al.: Prevalence and risk factors of peripheral vascular disease in a selected South Indian population: the Chennai Urban Population Study. Diabetes Care, 2000; 23:1295–1300.
30.
MohanV, DeepaR, RaniSS, et al.: Prevalence of coronary artery disease and its relationship lipids in a selected population in South India: the Chennai Urban Population Study (CUPS No. 5). J Am Coll Cardiol, 2001; 38:682–687.
31.
GaleEAM: Historical aspects of T1D. www.diapedia.org/type-1-diabetes-mellitus/2104085134/historical-aspects-of-type-1-diabetes
32.
SecrestAM, BeckerDJ, KelseySF, et al.: All-cause mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes: the Allegheny County T1Dregistry. Diabetes Care, 2010; 33:2573–2579.
33.
PambiancoG, CostacouT, EllisD, et al.: The 30-year natural history of T1D complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes, 2006; 55:1463–1469.
34.
LivingstoneSJ, LevinD, LookerHC, et al.; Scottish Diabetes Research Network epidemiology group: Scottish Renal Registry. Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008–2010. JAMA, 2015; 313:37–44.
35.
HarjutsaloV, ForsblomC, GroopPH: Time trends in mortality in patients with type 1 diabetes: nationwide population-based cohort study. BMJ, 2011; 343:d5364.
36.
SecrestAM, WashingtonRE, OrchardTJ: Mortality in type 1 diabetes. In: Cowie CC, Casagrande SS, Menke A, et al., eds. Diabetes in America. 3rd ed. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US), 2018 Chapter 35.
37.
OtaniT, KasaharaT, MiuraJ, et al.: Clinical background of Japanese patients with T1D mellitus who have received insulin therapy for 50 years or longer. Diabetol Int, 2019; 10:288–294.
38.
MogensenCE, KeaneWF, BennettPH, et al.: Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet, 1995; 346:1080–1084.
39.
GillGV, DaousiC, BarnettAH, et al.: Chronic kidney disease in long duration T1D lasting more than 50 years. Curr Med Res Opin, 2009; 25:395–400.
40.
BillowA, AnjanaRM, NgaiM, et al.: Prevalence and clinical profile of metabolic syndrome among type 1 diabetes mellitus patients in southern India. J Diabetes Complications, 2015; 29:659–664.
41.
PurnellJQ, ZinmanB, Brunzell JD; DCCT/EDIC ResearchGroup: The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study. Circulation, 2013; 127:180–187.
42.
AnjanaRM, ShanthiraniCS, UnnikrishnanR, et al.: Regularity of follow-up, glycemic burden, and risk of microvascular complications in patients with type 2 diabetes: a 9-year follow-up study. Acta Diabetol, 2015; 52:601–609.
43.
PerkinsBA, LovblomLE, LanctôtSO, et al.: Discoveries from the study of longstanding type 1 diabetes. Diabetologia, 2021; 64:1189–1200.
44.
KesavadevJ., SadikotS. M., Saboo, B., et al.: Challenges in Type 1 diabetes management in South East Asia: descriptive situational assessment. Indian J Endocrinol Metab, 2014; 18:600–607.
45.
PraveenPA, MadhuSV, MohanV, et al.: Registry of Youth Onset Diabetes in India (YDR): rationale, Recruitment, and Current Status. J Diabetes Sci Technol, 2016; 10:1034–1041.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
